Biodegradable implants degrade in a biologic environment. The use of bioabsorbable implants in spine surgery is expanding at a rapid pace. Their future as a carrier of biological agents, such as bone morphogenetic proteins and bone graft exten ders, their radiolucency, and their eventual resorption make them an ideal implant for use in spinal degenerative disease. For spine fixation, ideally these implants should have mechanical characteristics equal to those of standard metal implants and would degrade with the healing process, so that fixation is not lost before adequate healing and load is gradually transferred to the healing tissue. Several new experimental bioabsorbable devices are in the process of consideration as spinal implants. These include a myriad of posterior lumbar interbody fusion devices, anterior spinal plates, and a variety of screw and mesh designs.
INTroducTIoN

Basic Bioabsorbable Implants
Biodegradable implants degrade in a biologic environment. Their breakdown products are incorporated into normal cellular physiologic and biochemical processes with no immunogenic or mutagenic tendency. The use of bioabsorbable implants in spine surgery is expanding at a rapid pace. Biomechanical studies have demonstrated their ability to stabilize effectively a degenerative cervical and lumbar motion segment. Their future as a carrier of biological agents, such as bone morphogenetic proteins and bone graft extenders, their radiolucency, and their eventual resorption make them an ideal implant for use in spinal degenerative disease. For spine fixation, ideally these implants should have mechanical characteristics equal to those of standard metal implants and would degrade with the healing process, so that fixation is not lost before adequate healing and load is gradually transferred to the healing tissue. But, currently available polymers do not have mechanical characteristics equal to those of metal implants [1] [2] [3] (Table 1 ).
Flexible and less rigid bioabsorbable implants confer the advantage of stabilizing the motion segments while, over time, allowing a greater transfer of load to the host spine during implant resorption, potentially minimizing junctional degeneration.
Type of Implants
Polyglycolic acid (PGA) and polylactic acid (PLA) implants have been widely used, including rods, screws and plates, are available (Fig. 1) . Majority of clinical applications for these new polymers have involved tension band plating in the lumbar and anterior cervical spine, anterior spinal interbody reconstruction, posterior bone graft containment, and bone graft harvest site reconstruction.
Biodegradation
It should degrade with the healing process, so that fixation is not lost before adequate healing and load is gradually transferred to the healing tissue. Degradation occurs by several mechanisms (Table 2) , including hydrolysis and enzymatic degradation. Polymer degradation leads to oligomers and monomers which follow the routes mentioned in Table 2 . The final products [CO 2 and H 2 O products of the tricitric acid cycle (TCA cycle)] are excreted or used by the body. Polyglycolic acid and polydioxanone (PDS) degradation products can also be excreted by the kidneys. It is also known that PGA degradation is partially performed by enzymes, such as esterase. Enzymes also seem to take part in PLA degradation.
Polymer breakage produces products that lower the regional pH and thus accelerate the procedure. The final degradation of polymer debris is done by macrophages and giant cells followed by mild local tissue reaction around absorbable implants. This leads to production of a thin macrophage layer with incidentally multinucleated giant cells surrounded by a mild connective tissue capsule. That is responsible for many adverse effects.
JOSS
Biocompatibility
Biodegradable materials should be biocompatible. Not only that it should avoid eliciting inflammatory and immunogenic responses but also its degraded materials should not have any local and the systemic response. 8 The biocompatibility of a polymer depends on its chemical structure and the processing method that produces it. During a polymerization process, an initiator, a monomer, and sometimes a catalyst are needed, and these materials often remain in preformed implants even after purification. Toxicity and concentration of residual unreacted monomers or initiators should be considered when assessing biocompatibility. Removal of these potentially toxic components is usually effected by prolonged rinsing in aqueous solution. Biocompatibility of the remaining material is confirmed in vitro by cytotoxicity assays. In vivo observation of the inflammatory response after implantation in animal models is also an important step before clinical application can be considered.
Clinically, significant foreign-body reactions are far more rarely seen with PLA than with PGA. In short-term studies, the biocompatibility has been acceptable with no clinical manifestations of foreign-body reactions.
Processability: Sterility, reproducibility and Ease of Handling
It should be possible to sterilize biodegradable implants without affecting their chemical or physical properties and to produce and package them on a large scale for practical and economic uses. Factors, such as viscosity, curing time and implant shape, should also be optimized for injectable scaffolds to facilitate their use during complex surgical procedures.
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STudIES
Many of the biomechanical and fusion studies of bioabsorbable implants have been conducted in animal models. In particular, sheep and goats have been most widely used as test subjects for bioabsorbable products in trials to discern their effectiveness and safety. Studies have shown that the biomechanical environment of axial loading of the sheep and goat spine is comparable to that of the human spine. 13, 15, 16, 19, 20 Adverse effect includes migration of implant, growth disturbance, rigidity, infection, effects on cellular level and implant removal operations. 4 Due to its radiolucent nature, diagnosis can be difficult to make postoperatively in a persistently painful condition.
dIScuSSIoN
Clearly, future work in the area of orthopedic biomaterials should be focused on the reduction of the foreign-body response. Reducing the crystallinity of the polymer or controlling the pH in the degrading implants may help to reduce the incidence of the foreign-body response. Several new experimental bioabsorbable devices are in the process of consideration as spinal implants. These include a myriad of posterior lumbar interbody fusion devices, anterior spinal plates, and a variety of screw and mesh designs. 
Advantage
Biodegradable implants provide the advantages of gradual load transfer to the healing tissue; hence, less bone resorption, reduced or no need for implant removal, and radiolucency, which facilitates postoperative radiographic evaluation and no hindrance or complication in 2nd surgey, leading to reduced trauma to soft tissue hence reduced total cost of surgery and cross infection. They can be engineered to alter their degradation characteristics and material properties. These biodegradable implants are safe as they are biocompatible hence less risk of metal allergic reactions. As compared to metallic implants, there is no longterm implant palpability hence patient compliance. There is no implant temperature sensitivity so short-wave diathermy and microwave diathermy can be used
